SLAIN2: A Potential Drug Target and Biomarker (G57606)

Target Name: SLAIN2

NCBI ID: G57606

SLAIN2

Other Name(s): SLAIN motif family member 2 | SLAIN motif-containing protein 2 | KIAA1458 | SLAI2_HUMAN

SLAIN2: A Potential Drug Target and Biomarker

SLAIN2, short for Small molecule-Induced Leukemia Inhibitors 2, is a protein that is expressed in various tissues of the body, including the brain, spleen, and bone marrow. It is a member of the SLAIN motif family, which is a family of proteins that are known to play a role in the development and progression of various diseases, including leukemia.

The SLAIN2 protein is known for its ability to induce apoptosis, which is the process by which cells undergo programmed cell death. This process is important for the regulation of cell growth and the removal of damaged or unnecessary cells. In cancer, abnormal cell division and Apoptosis can contribute to the development and progression of the disease.

SLAIN2 has also been shown to play a role in the regulation of cell proliferation. In addition, SLAIN2 has been shown to interact with various signaling pathways, including the PI3K/Akt signaling pathway. This pathway is involved in the regulation of cell growth, survival , and angiogenesis.

SLAIN2 has also been shown to be involved in the regulation of cellular immune responses. In addition, SLAIN2 has been shown to interact with the T-cell receptor, which is involved in the regulation of cellular immune responses.

SLAIN2 has also been shown to play a role in the regulation of cellular stress responses. In addition, SLAIN2 has been shown to interact with the stress response protein, p21. This protein is involved in the regulation of cell cycle progression and apoptosis.

In conclusion, SLAIN2 is a protein that has been shown to play a role in the development and progression of various diseases, including leukemia. Its ability to induce apoptosis and regulate cell proliferation, immune responses, and cellular stress responses makes it a potential drug target and biomarker. Further research is needed to fully understand the role of SLAIN2 in disease and to develop effective treatments.

Protein Name: SLAIN Motif Family Member 2

Functions: Binds to the plus end of microtubules and regulates microtubule dynamics and microtubule organization. Promotes cytoplasmic microtubule nucleation and elongation. Required for normal structure of the microtubule cytoskeleton during interphase

The "SLAIN2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLAIN2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets